Daisuke Honda

6PUBLICATIONS
9CO-AUTHORS
Catalysis and mechanisms of reactionsMolecular medicineToxicology (incl. clinical toxicology)Clinical pharmacology and therapeuticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 22, 2026
Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism.

Fumihiko Koiwa, Daisuke Honda, Seigo Akari

|Dec 04, 2023
Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study.

Daijo Inaguma, Fumihiko Koiwa, Masanori Tokumoto

|Sep 11, 2023
Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Randomized Placebo-Controlled Trial.

Takashi Shigematsu, Fumihiko Koiwa, Yoshitaka Isaka

|Jun 28, 2022
First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties.

Junichiro James Kazama, Fumihiko Koiwa, Keitaro Yokoyama

|Mar 26, 2022
First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants.

Fumihiko Koiwa, Rie Yazawa, Masafumi Fukagawa

|Jan 27, 2018
Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).

Takashi Wada, Tatsuo Hosoya, Daisuke Honda

Pageof 1

Frequent Collaborators

2 joint publications

Masafumi Fukagawa

2 joint publications

Tadao Akizawa

1 joint publications

Takashi Shigematsu

1 joint publications

Fumihiko Koiwa